Skip to main content

Month: June 2023

Palisade Bio Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Live webcast fireside chat on Thursday, June 22nd at 11:30 AM ET Carlsbad, CA, June 14, 2023 (GLOBE NEWSWIRE) — Palisade Bio (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that J.D. Finley, Chief Executive Officer of Palisade Bio will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 22, 2023 at 11:30 AM ET. The exponential growth in knowledge and expertise in science and medicine continues to drive opportunities in the healthcare space. These include multiple therapeutic categories and emerging technologies, which presenting companies at this year’s Maxim Healthcare Conference are focused on, and for many, that includes key data-driven events in 2023. Maxim Senior Analysts...

Continue reading

Conduent Transportation Selected to Provide New EMV Contactless Payment Technology for Buses in Verona, Italy

Pilot project of the new technology will begin on a Verona airport bus line this monthConduent Verona Passenger using Conduent validatorMILAN, Italy and FLORHAM PARK, N.J., June 14, 2023 (GLOBE NEWSWIRE) — Conduent Transportation, a global provider of smart mobility technology solutions and business unit of Conduent Incorporated (Nasdaq: CNDT), today announced its selection by transport operator Azienda Trasporti Verona (ATV) to provide new contactless payment technology for the public buses in Verona, Italy.Conduent will provide contactless EMV (Europay, Mastercard and Visa) payment technology that will allow passengers to pay with debit and credit cards, as well as NFC-enabled digital wallets on board ATV buses. This month, Conduent and ATV are starting a pilot project of the EMV technology on the Airlink bus service between...

Continue reading

LiveOne Updates on PodcastOne’s Planned Spin-Out; Strengthens Balance Sheet

– PodcastOne’s S-1 Registration Statement Declared Effective by the SEC –  Repays $3 Million of PodcastOne’s convertible debt ​-​ Increases ​Special ​Dividend from 12% ​to ~19% – Extends Record Date to Coincide with Approval for Planned Listing on National Exchange ​-​ PodcastOne Plans to File Its 2023 FY Audited Financial Statements by June 29, 2023 as Requested by Nasdaq as Part of Its New Listing Review -​ LiveOne to Own ~74% of PodcastOne’s Outstanding Shares Post Spin-Out – Each LiveOne Share Held as of Record Date Expected to Receive ~.048 Shares of PodcastOne in the Special Dividend LOS ANGELES, CA, June 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, provided today an update on its planned spin-out...

Continue reading

Multitude publishes its bond prospectus and applies for listing of bonds on Nasdaq Stockholm

Multitude publishes its bond prospectus and applies for listing of bonds on Nasdaq Stockholm Helsinki, 14 June 2023 – Multitude SE (“Multitude” or the “Company“) has issued senior unsecured bonds of EUR 50,000,000 under a framework of up to EUR 150,000,000 on 21 December 2022 on the Swedish and German bond market. The bonds carry a floating interest rate of EURIBOR 3m + 7.50 per cent. per annum and matures in December 2025 (the “Bonds“). The Finnish Financial Supervisory Authority (the “FIN-FSA“) (Fi. Finanssivalvonta) has on 13 June 2023 approved the listing prospectus of the Bonds (the “Prospectus“), and the FIN-FSA has on 14 June 2023, at the request of the Company, notified the Swedish Financial Supervisory Authority (Sw. Finansinspektionen), with a certificate of approval...

Continue reading

Artificial Intelligence Technology Solutions Extends Commitment of No Reverse Stock Split

Detroit, Michigan, June 14, 2023 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions has filed a Form 8-K with the Securities and Exchange Commission that provides details on the company’s corporate charter amendment that has been filed with the Nevada Secretary of State. The charter amendment extends the Company’s commitment not to engage in a reverse stock split of its Common Stock before January 1, 2025, unless the Company is uplisting to NASDAQ or the NYSE. “I deeply value and appreciate the support and commitment shown by the remarkable AITX investor community,” said Steve Reinharz, CEO of AITX. “I want to reiterate my unequivocal stance on not pursuing any reverse stock splits. To provide you with utmost assurance,...

Continue reading

NeuBase Announces 1-for-20 Reverse Stock Split

PITTSBURGH, June 14, 2023 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without triggering the immune system, today announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, to be effective as of 5:00 p.m. Eastern Time today, June 14, 2023. The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Thursday, June 15, 2023. Following the reverse stock split, the Company’s common stock will continue to trade on The Nasdaq Capital Market under the symbol “NBSE” with the new CUSIP number, 64132K201. The reverse stock split is intended for the Company to regain compliance with...

Continue reading

Results of Annual General Meeting and General Meeting

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting and General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain, announces that at its Annual General Meeting and subsequent General Meeting held earlier today, all resolutions put to the Company’s shareholders were duly passed. The full text of, inter alia, the resolutions proposed and passed at the Annual General Meeting and General Meeting can be found in the Notices of the Annual General Meeting and General Meeting on the Company’s website at:https://biodexapharma.com/investors/corporate-governance//#company-informationFor more information, please contact:Biodexa Pharmaceuticals...

Continue reading

Skkynet Achieves Record Sales Growth YoY

Skkynet Announces Fiscal Quarter-end Results for Q2 2023 With Record Sales Growth of 16% MISSISSAUGA, ONTARIO, June 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Skkynet Cloud Systems, Inc. (“Skkynet” or “the Company”) (OTCQB: SKKY) is pleased to announce its quarter-end operating and financial results for the period ended April 30, 2023. The Company reported a record second quarter revenue of $625,464 compared to $540,093 for the same period in 2022, a 16% year over year revenue growth. Comprehensive loss from operations for the 3-month period was $90,740 compared to $19,475 for the same period in 2022 due to increased headcount for expanding operations and capabilities, including development of new DataHub version 11, due for beta release in Q3.  Development of applications to leverage AI within the DataHub product stack is...

Continue reading

Progressive Reports May 2023 Results

MAYFIELD VILLAGE, OHIO, June 14, 2023 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for May 2023:  May(millions, except per share amounts and ratios; unaudited)   2023       2022     ChangeNet premiums written $ 4,321.4     $ 3,724.3     16   %Net premiums earned $ 4,490.4     $ 3,763.6     19   %Net income $ 108.2     $ 92.1     17   %Per share available to common shareholders $ 0.18     $ 0.15     17   %Total pretax net realized gains (losses) on securities $ (35.3 )   $ (89.0 )   (60 ) %Combined ratio   99.0       96.5     2.5 pts.Average equivalent common shares   587.0       586.4     0   %  May(thousands; unaudited) 2023     2022     ChangePolicies in Force              Personal Lines              Agency – auto 8,423.2     7,658.9     10   %Direct...

Continue reading

Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center

Pure-Vu system featured in live case during an underwater large polyp resection in the colon Over 1,000 physicians registered for IECED Live Endoscopy Course from across Latin America Pure-Vu Gen 4 Gastro and Colon on track for FDA submission in Q4 2023FORT LAUDERDALE, Fla., June 14, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that the Pure-Vu Gen 4 Gastro and Colon system was featured during the 9th Ecuadorian Institute of Digestive Diseases (IECED) Live Endoscopy Course 2023 at the Pentax Learning Center, which is considered one of the most important digestive medicine annual events held in the Latin American region with over 1,000 physicians registered. During a live case...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.